Dual and/or selective DNA-PK, PI3K inhibition and isoform selectivity of some new and known 2-amino-substituted-1,3-benzoxazines and substituted-1,3-naphthoxazines

被引:12
作者
Morrison, Rick [1 ]
Belz, Tyson [1 ]
Ihmaid, Saleh K. [1 ]
Al-Rawi, Jasim M. A. [1 ]
Angove, Michael J. [1 ]
机构
[1] La Trobe Univ, Sch Pharm & Appl Sci, Bendigo, Vic 3552, Australia
关键词
Synthesis; 2-Amino-substituted-1,3-benzoxazines; 2-Amino-naphthoxazines; DNA-PK; PI3K isoform inhibition and selectivity; DEPENDENT PROTEIN-KINASE; STRUCTURAL ELUCIDATION; ANTIPLATELET ACTIVITY; CANCER-THERAPY; REPAIR; DISCOVERY;
D O I
10.1007/s00044-014-1037-6
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The 2-morpholino-substituted-benzoxazines 7a and 7b were used in the synthesis of 2-morpholino-di-Obenzyl, O-pyridin-2yl, 3-yl and 4yl-methoxy)-1,3-benzoxazines 8a-8d, and N-(2-morpholino-4-oxo-4H-benz[e] [1,3] oxazin-7-yl)-N-(pyridin-2-and-3-ylmethyl) acetamides 8e and 8f. The DNA-dependent protein kinase (DNA-PK) and phosphatidylinositol 3-kinase (PI3K) alpha, beta, gamma, and delta isoforms were studied for the new compounds 8a-8f and PI3K for the 18 previously synthesized compounds 9-26. The most active DNA-PK inhibitors were the 2-morpholino-O-substituted linear or angular naphthoxazine compounds 18-20 and 21-22 which showed potent and selective DNA-PK activity (IC50 from 0.01 to 2.43 mu M) over PI3K. 8-(2-(4-Methylpiperazin-1-yl) ethoxy)-2-morpholino compound 13, and 8-methyl-2-(pyridin-3-yl(pyridin-3-ylmethyl) amino)-7-(pyridin-3-ylmethoxy) compound 25 showed selective DNA-PK inhibition. 2-morpholino-8-substituted-benzoxazine 9 (8-ph) and 10-12 (8-(pyridine-2-, 3-, or 4-ylmethoxy) showed high-to-moderate inhibition of PI3K and DNA-PK. A similar pattern for DNA-PK nonselectivity over PI3K was observed for compounds with 7,8-O-bis-substituted 8a, 8c, and 8d. No DNA-PK selectivity over PI3K was observed regardless whether the substitution was phenyl, pyridin-2-ylmethoxy, pyridin-3-ylmethoxy, and pyridin-4-ylmethoxy.
引用
收藏
页码:4680 / 4691
页数:12
相关论文
共 27 条
[1]   Slow self-activation enhances the potency of viridin prodrugs [J].
Blois, Joseph ;
Yuan, Hushan ;
Smith, Adam ;
Pacold, Michael E. ;
Weissleder, Ralph ;
Cantley, Lewis C. ;
Josephson, Lee .
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (15) :4699-4707
[2]  
Brown TM, 1992, EDUC CHEM, P22
[3]   1-Substituted (Dibenzo[b,d]thiophen-4-yl)-2-morpholino-4H-chromen-4-ones Endowed with Dual DNA-PK/PI3-K Inhibitory Activity [J].
Cano, Celine ;
Saravanan, Kappusamy ;
Bailey, Chris ;
Bardos, Julia ;
Curtin, Nicola J. ;
Frigerio, Mark ;
Golding, Bernard T. ;
Hardcastle, Ian R. ;
Hummersone, Marc G. ;
Menear, Keith A. ;
Newell, David R. ;
Richardson, Caroline J. ;
Shea, K. ;
Smith, Graeme C. M. ;
Thommes, Pia ;
Ting, Attilla ;
Griffin, Roger J. .
JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (16) :6386-6401
[4]   The life and death of DNA-PK [J].
Collis, SJ ;
DeWeese, TL ;
Jeggo, PA ;
Parker, AR .
ONCOGENE, 2005, 24 (06) :949-961
[5]   DNA repair dysregulation from cancer driver to therapeutic target [J].
Curtin, Nicola J. .
NATURE REVIEWS CANCER, 2012, 12 (12) :801-817
[6]  
Desage El-Murr M., 2008, BIOORG MED CHEM LETT, V18, P4885
[7]   Isoform-Specific Phosphoinositide 3-Kinase Inhibitors Exert Distinct Effects in Solid Tumors [J].
Edgar, Kyle A. ;
Wallin, Jeffrey J. ;
Berry, Megan ;
Lee, Leslie B. ;
Prior, Wei Wei ;
Sampath, Deepak ;
Friedman, Lori S. ;
Belvin, Marcia .
CANCER RESEARCH, 2010, 70 (03) :1164-1172
[8]   Modulation of DNA repair by pharmacological inhibitors of the PIKK protein kinase family [J].
Finlay, M. Raymond V. ;
Griffin, Roger J. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (17) :5352-5359
[9]   Angiogenesis selectively requires the p110α isoform of PI3K to control endothelial cell migration [J].
Graupera, Mariona ;
Guillermet-Guibert, Julie ;
Foukas, Lazaros C. ;
Phng, Li-Kun ;
Cain, Robert J. ;
Salpekar, Ashreena ;
Pearce, Wayne ;
Meek, Stephen ;
Millan, Jaime ;
Cutillas, Pedro R. ;
Smith, Andrew J. H. ;
Ridley, Anne J. ;
Ruhrberg, Christiana ;
Gerhardt, Holger ;
Vanhaesebroeck, Bart .
NATURE, 2008, 453 (7195) :662-666
[10]   Discovery of potent chromen-4-one inhibitors of the DNA-dependent protein kinase (DNA-PK) using a small-molecule library approach [J].
Hardcastle, IR ;
Cockcroft, X ;
Curtin, NJ ;
El-Murr, MD ;
Leahy, JJJ ;
Stockley, M ;
Golding, BT ;
Rigoreau, L ;
Richardson, C ;
Smith, GCM ;
Griffin, RJ .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (24) :7829-7846